Ophthalmology
The Lead
Researchers Develop Easy and Effective Therapy to Restore Sight
June 13, 2013 11:02 am | by University of California - Berkeley | News | Comments
Researchers at the University of California, Berkeley, have developed an easier and more effective method for inserting genes into eye cells that could greatly expand gene therapy to help restore sight to patients with blinding diseases ranging from inherited defects like retinitis pigmentosa to degenerative illnesses of old age, such as macular degeneration.
UBC Engineer Helps Pioneer Flat Spray-On Optical Lens
May 23, 2013 10:43 am | by University of British Columbia | News | Comments
A University of British Columbia engineer and a team of U.S. researchers have made a...
UBC Engineer Helps Pioneer Flat Spray-On Optical Lens
May 23, 2013 10:43 am | by University of British Columbia | News | Comments
A University of British Columbia engineer and a team of U.S. researchers have made a...
New Study Finds Blind People Have the Potential to Use Their 'Inner Bat' to Locate Objects
May 21, 2013 11:51 am | by University of Southampton | News | Comments
New research from the University of Southampton has shown that blind and visually impaired...
New Array Measures Vibrations Across Skin May Help Engineers Design Tactile Displays
June 14, 2013 9:16 am | by Massachusetts Institute of Technology | News | CommentsIn the near future, a buzz in your belt or a pulse from your jacket may give you instructions on how to navigate your surroundings. Think of it as tactile Morse code: vibrations from a wearable, GPS-linked device that tell you to turn right or left, or stop, depending on the pattern of pulses you feel. Such a device could free drivers from having to look at maps, and could also serve as a tactile guide for the visually and hearing impaired.
Transparent Electrode Enables Electronics on Contact Lens
June 4, 2013 12:10 pm | by Eunhee Song, UNIST | News | CommentsA hybrid transparent and stretchable electrode could open the new way for flexible displays, solar cells, and even electronic devices fitted on a curvature substrate such as soft eye contact lenses, by the UNIST (Ulsan National Institute of Science and Technology) research team.
Valeant to Buy Bausch + Lomb for $8.7B
May 28, 2013 10:29 am | by Linda A. Johnson, AP Business Writer | News | CommentsCanadian drugmaker Valeant Pharmaceuticals has agreed to pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology business. Valeant said Monday that the cash deal will help it capitalize on increasing demand for contact lenses and other products because of aging populations, growing demand in emerging markets and increasing rates of diabetes.
Bausch + Lomb Receives FDA Approval for the TRULIGN Toric Posterior Chamber Intraocular Lens
May 22, 2013 10:33 am | by Bausch + Lomb | News | CommentsBausch + Lomb, the global eye health company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the TRULIGN™ Toric posterior chamber intraocular lens (IOL). The TRULIGN Toric intraocular lens is the first toric IOL that corrects for astigmatism and, unlike other standard toric lenses, has the additional capacity to deliver improved vision across a natural range of focus.
NVISION Laser Eye Centers First in the Nation to Offer Avellino-GENE Detection System Test to Protect Patients from Blindness
May 14, 2013 8:04 am | by PR Newswire | News | CommentsMENLO PARK, Calif., May 14, 2013 /PRNewswire/ -- Avellino Lab USA, developer of the only genetic test available worldwide for Avellino Corneal Dystrophy (ACD), today announced that California-based NVISION Laser Eye Centers is the first provider in the United States to offer patients...
Glasses Read to the Blind
April 25, 2013 11:24 am | by Florida International University | Videos | CommentsA unique pair of eyeglasses developed by a Florida International Univ. student team could revolutionize the lives of the blind, enabling them to walk into a library or a store, pick up any book or a can of soup and read it. The Eyetalk concept has been hailed by venture investors as a potentially breakthrough product that could make a difference for disabled people worldwide.
HelpMeSee Selects Moog to Develop Virtual Reality Eye Surgery Simulator
April 25, 2013 10:04 am | by HelpMeSee | News | CommentsHelpMeSee has achieved a significant milestone in medical simulation by successfully testing virtual reality surgical training simulators as a proof of concept. This success led HelpMeSee to select Moog for a joint development contract to design and produce a high-fidelity virtual reality Eye Surgery Simulator and courseware model to train cataract surgeons...
Treatment Available for Macular Degeneration Low Vision in Connecticut
April 23, 2013 10:43 am | by PR Newswire | News | CommentsDANBURY, Conn., April 23, 2013 /PRNewswire-iReach/ -- Prismatic Magnifying Readers (PMRs) can often help people with macular degeneration, glaucoma, diabetic retinopathy and others with low vision who are having difficulty reading by providing extra magnification and comfort. The...
ZEISS Cataract Suite Featuring CALLISTO Eye Introduced at Annual Cataract and Refractive Surgery Congress in San Francisco
April 20, 2013 3:09 pm | by The Associated Press | News | CommentsSAN FRANCISCO & DUBLIN, Calif. & JENA, Germany--(BUSINESS WIRE)--Apr 20, 2013--Carl Zeiss Meditec is introducing the ZEISS Cataract Suite featuring the new CALLISTO eye® OR management system, which recently received US FDA 510k clearance, at the 2013 American Society of Cataract and...
STAAR Surgical Celebrates Over 350,000 Successful Visian® ICL™ Implants at ASCRS Symposium in San Francisco
April 17, 2013 3:33 pm | by PR Newswire | News | CommentsMONROVIA, Calif., April 17, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced its significant participation in the upcoming annual Symposium of the American Society for...
Advantages of OptiMedica’s Catalys® Precision Laser System to Be Validated in 31 Clinical Presentations at ASCRS 2013
April 17, 2013 7:00 am | by The Associated Press | News | CommentsSUNNYVALE, Calif.--(BUSINESS WIRE)--Apr 17, 2013--OptiMedica Corp. has announced that its Catalys Precision Laser System will be the subject of 31 accepted clinical presentations at the 2013 American Society of Cataract and Refractive Surgery (ASCRS) conference, April 19 - 23, in San Francisco....
Alcon Labs issues hazard alert on certain intraocular lenses
April 12, 2013 3:11 pm | by Mass Device | News | CommentsAlcon Laboratories in conjunction with Australian healthcare regulators issued a warning on certain intraocular lenses after receiving reports of higher-than-expected rates of accelerated endothelial cell loss. Alcon warned that a 5-year study of its AcrySof Cachet Phakic Lenses uncovered that about 1 in 100 required removal as a result of ECL...
Sony Announces First East and West Coast Installations of 3D Imaging Solution for Ophthalmic Surgery
April 11, 2013 11:17 am | by PR Newswire | News | CommentsPARK RIDGE, N.J., April 11, 2013 /PRNewswire/ -- Sony Electronics, a leader in providing innovative imaging solutions for microsurgery, announces the first east and west coast installations of its end-to-end 3D imaging solution for ophthalmic surgery. Robert Cionni, M.D.,...
ChromaGen Launches Life-Changing Lens Technology In Houston, Texas
April 10, 2013 2:55 pm | by PR Newswire | News | CommentsHOUSTON, April 10, 2013 /PRNewswire/ -- Words that move from left to right or up and down, words that are blurry or come in and out of focus or words that appear to float on the page, seeing double words or double sentences, re-reading the same lines - these are some of the reading...
Recall: Hoya Surgical Optics Pulls Intraocular Lenses amid Adverse Event Reports
April 5, 2013 10:29 am | by Mass Device | News | CommentsSingapore-based Hoya Surgical Optics recalled 5 models of its intraocular lenses after receiving reports of higher-than expected rates of inflammation from doctors in several countries. Healthcare regulators in the U.K. and in Australia have both reported the recall, asking doctors to stop using the implants immediately.
Laser Technology Expands Treatment Options For Cataract Surgery
April 4, 2013 12:33 pm | by Globe Newswire | News | CommentsFor the millions of people needing cataract surgery each year, there is now a new option in the way doctors can perform the procedure. In this new technique, surgeons use an FDA approved device called the "Femtosecond Laser" to aid in performing a number of the steps in cataract surgery.
MedFocusCapital Partners Announces See.Hear.Live.Better! Alliance
April 4, 2013 9:07 am | by PR Newswire | News | CommentsSARASOTA, Fla., April 4, 2013 /PRNewswire/ -- MedFocusCapital Partners, Inc., an innovator in the eye care industry, announces See.Hear.Live.Better!, an alliance of healthcare service providers backed by leading product manufacturers, all focused on improving the quality of life through...
LensAR Lands Another FDA Clearance for Cataract Laser Surgery
April 3, 2013 11:46 am | by Mass Device | News | CommentsThe laser cataract surgery market has another player, now that the FDA's cleared its laser surgery device for another type of incision used during cataract surgery procedures. LensAR said it won 510(k) clearance from the FDA for its laser cataract surgery device for arcuate incisions to the edge of the cornea.
FDA Cleared ChromaGen Lenses Are A Life-Changing Aid For People Struggling With Dyslexia And Other Reading Problems
March 27, 2013 3:30 pm | by PR Newswire | News | CommentsKENNETT SQUARE, Pa., March 27, 2013 /PRNewswire/ -- Words that move from left to right or up and down, words that are blurry or come in and out of focus or words that appear to float on the page, seeing double words or double sentences, re-reading the same lines - these are some of the...
pSivida Takes Another Stab at FDA Approval for Iluvien
March 27, 2013 9:51 am | by Mass Device | News | CommentsIt's been a rocky road for pSivida's Illuvien, a drug/device combination for diabetic macular edema, but the company hopes that new trial data will pave the way to regulatory approval in the U.S. Watertown, Mass.-based pSivida, which licenses the Iluvien technology to Alimera Sciences, said the two companies plan to re-submit a new drug application to the FDA by the end of this month.
Federal Circuit Defends InSite Vision's Win over San Francisco University
March 26, 2013 3:05 pm | by Mass Device | News | CommentsInSite Vision eked out a narrow win against the University of California in San Francisco in a patent battle over eye treatment. Alameda, Calif.-based InSite touted a split U.S. Court Federal Circuit Court of Appeals decision in its favor, upholding the U.S. Patent & Trademark Office's panel ruling.
Photovoltaic Polymer Lets Damaged Retinas See the Light
March 17, 2013 2:00 pm | by Massachusetts Institute of Technology | News | CommentsA light-sensitive polymer could offer a new way to develop artificial retinas. A team of neuroscientists and materials scientists has shown that a photovoltaic polymer can restore light-sensing capabilities to damaged retinas, offering hope of a simple way to restore vision to many people with degenerative eye disease.
Cardiovascular Systems Completes PMA Submission of Orbital Atherectomy System for Coronary Artery Disease Treatment
March 15, 2013 8:00 am | by The Associated Press | News | CommentsST. PAUL, Minn.--(BUSINESS WIRE)--Mar 15, 2013--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced today that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its orbital atherectomy system, used to treat calcified coronary...
EyeTechCare Raises $13M for Ultrasound Glaucoma Treatment
March 13, 2013 4:08 pm | by Mass Device | News | CommentsEyeTechCare said it landed nearly $13 million in its 3rd round of funding, aiming to use the cash to fund a clinical trial of its EyeOP1 ultrasound glaucoma treatment, which has been on the market in Europe since Rillieux-la-Pape, France-based EyeTechCare said the backers include private investor Dr. Bernard Chauvin and prior investors Omnes Capital and France's SHAM insurance company.
St. Jude Medical launches Ilumien Optis in Japan
March 12, 2013 10:03 am | by Mass Device | News | CommentsSt. Jude Medical (NYSE:STJ) said its launched the Ilumien Optis device in Japan, calling it the only medical device on the market to combine fractional flow reserve and optical coherence tomography technology to allow doctors to evaluate the state and severity of coronary lesions.
